Quality Systems

Oct 01, 2016
BioPharm International
Ensuring that drugs retain their safety and efficacy requires careful selection of temperature-control technologies.
Sep 30, 2016
By BioPharm International Editors
Could grading finished-drug manufacturers on their quality and efficiency lead to greater transparency, improve quality and reduce drug shortages?
Sep 23, 2016
By BioPharm International Editors
Hebei Yuxing Bio-Engineering Co. Ltd. was cited for data integrity violations.
Sep 16, 2016
By BioPharm International Editors
EMA has recommended halting supply of non-critical drugs from Pharmaceutics International Inc. because of GMP failures.
Sep 14, 2016
By BioPharm International Editors
FDA sent a warning letter to an Illinois compounding pharmacy for violations of the Federal Food, Drug, and Cosmetic Act.
Sep 12, 2016
By BioPharm International Editors
The company voluntarily recalled the product due to detached needles on the syringe in the kit.
Sep 07, 2016
By BioPharm International Editors
FDA issued a warning letter to Lima & Pergher Industria e Comercio S/A for CGMP violations.
Sep 07, 2016
By BioPharm International Editors
The Indian facility was cited for a range of quality and data integrity violations.
Sep 01, 2016
By BioPharm International Editors
FDA cites two Xinxiang Tuoxin Biochemical facilities with CGMP deviations.
Sep 01, 2016
BioPharm International
Innovations in electrophoresis and chromatography upstream of protein characterization can accelerate research.
native1_300x100
lorem ipsum